Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NNNNNNNN
6 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ANBIO BIOTECHNOLOGY

GEODE CAPITAL MANAGEMENT, LLC holds 26,736 shares of NNNN (ANBIO BIOTECHNOLOGY), worth $366,550 as of 2026-Q2. The position was increased (+3.8% shares).

Current Value

$366,550

Current Shares

26,736

Total Value Change

+$239,283

Total Shares Change

+9,676

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
26,736
+3.8%
$366,5500.0%$13.71
17
2026-Q1
Unchanged
25,763
0.0%
$661,8510.0%$23.11
0
2025-Q4
Unchanged
25,763
0.0%
$774,6930.0%$29.99
0
2025-Q3
Increased
25,763
+50.4%
$959,6710.0%$34.02
35
2025-Q2
Increased
17,130
+0.4%
$542,3350.0%$31.21
17
2025-Q1
New
17,060
-
$127,2670.0%$7.55
34

Other major holders of NNNN: MARSHALL WACE, LLP, UBS Group AG, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used